India and Switzerland signed a memorandum of understanding on intellectual property rights to promote the protection of IPRs. The MoU refers to issues relating to exchange information, experiences, best practices and more.
The USPTO has granted its requests for reexamination of TT Inc.'s patents relating a user interface for entering trade orders. The Requests for Reexamination address whether the patented features were in existence prior to TT's patents -- thus making the patents invalid.
The EPO intends to issue Opexa patent for “Autologous T Cell Vaccine Materials and Method,” a unique method-specific approach for generating a T-cell vaccine that attacks what is believed to be the underlying cause of multiple sclerosis (MS).